First highlighted as part of a study in 2021, a tooth-regrowing drug is set to finally enter human testing this year. We covered plans for the drug to come to clinical trials last year, and now, it seems that human trials have been officially scheduled.
The first phase of the human trials will kick off in September, with 30 healthy male adults participating in the trial. Each patient is missing at least one back tooth. Phase 2 has been tentatively scheduled for 2025 and will involve patients...